ICE Bioscience at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

ICE Bioscience brings 3 presentations to ENA 2026 in Barcelona, and exhibits at Booth 10. Its posters cover RIPTAC molecules and resistance to KRAS-targeted therapy. The RIPTACs link BRD4 to ER or AR so that target engagement depends on target expression, with the AR version reaching tumor-selective engagement in prostate cancer.

Organization	ENA 2026 Attendance
ICE Bioscience Beijing, China
ice-biosci.com CROs & CDMOsExhibitor Contract research organization offering target validation, compound screening and preclinical drug discovery services.	Booth Exhibiting at Booth 10 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Part of Poster session: Drug Resistance and Modifiers Characterization and Overcoming of KRAS-Targeted Therapy Resistance in Resistant Cancer Cell Lines Targeted agents Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Part of Poster session: Drug Design ER-BRD4 RIPTAC: Bridging Target Engagement to a Target-Dependent Therapeutic Window Drug design Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Part of Poster session: Drug Design AR–BRD4 RIPTAC Induces Expression-Dependent Ternary Complex Formation to Achieve Tumor-Selective Target Engagement in Prostate Cancer Drug design

Organization

ENA 2026 Attendance

ICE Bioscience

Beijing, China

ice-biosci.com

CROs & CDMOsExhibitor

Contract research organization offering target validation, compound screening and preclinical drug discovery services.

Booth

Exhibiting at Booth 10

Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm

Poster

Wed Nov 18
12–1:30pm
3:50–4:15pm
5:45–7pm